Global DNA Methylation Market to Reach US$ 4.5 Billion by 2032, Propelled by Increasing Prevalence of Chronic Diseases

April 14, 2023 | Healthcare

According to the latest report by IMARC Group, titled “DNA Methylation Market Report by Product (Consumables, Kits and Reagents, Enzymes, Instrument and Software), Technology (Polymerase Chain Reaction (PCR), Microarray, Sequencing, and Others), Application (Gene Therapy, Clinical Research, Diagnostics, and Others), End User (Hospital and Diagnostic Laboratories, Pharmaceutical and Biotechnology Companies, Research and Academia), and Region 2024-2032," the global DNA methylation market size reached US$ 1.4 Billion in 2023. Deoxyribonucleic acid (DNA) methylation refers to a biological process in which a methyl group is added to the cytosine base of a DNA molecule. It is an epigenetic modification process that alters gene expression patterns without changing the underlying DNA sequence. It is analyzed through various technologies, such as polymerase chain reaction (PCR), microarray, bisulfite sequencing, immunoprecipitation (IP), and nanopore sequencing. DNA methylation is widely used for disease diagnosis and prognosis, prenatal screening, drug development, epigenetic research, and forensic analysis. It provides a deeper understanding of disease mechanisms and progression, which aids in early disease detection, improving clinical outcomes, minimizing complications, and enhancing patient satisfaction. 


Global DNA Methylation Market Trends:

The escalating prevalence of chronic diseases, such as cancer, diabetes, hypertension, arthritis, Alzheimer’s disease, and cardiovascular diseases (CVDs), is one of the key factors driving the market growth. DNA methylation is widely used as a biomarker to identify epigenetic changes associated with certain conditions, thus allowing early disease detection, improving patient outcomes, and reducing healthcare costs. In addition to this, the rising geriatric population with high susceptibility to developing chronic conditions is acting as another growth-inducing factor. Furthermore, the increasing adoption of DNA methylation as a non-invasive diagnostic tool for monitoring diseases, which enhances patient comfort and reduces the risk of complications, is providing an impetus to the market growth. Additionally, the recent development of single-cell sequencing technology that allows fast, more accurate, and in-depth analysis of DNA methylation patterns is positively influencing the market growth. Moreover, the increasing applications of DNA methylation in prenatal screening to detect chromosomal abnormalities and identify various genetic disorders, such as down syndrome, muscular dystrophy, and cystic fibrosis, is facilitating the market growth. Other factors, including rising healthcare expenditure, the increasing utilization of DNA methylation to develop new plant varieties, extensive research and development (R&D) activities, and growing demand for precision medicine, are anticipated to drive the market growth. On account of the aforementioned factors, the market value is expected to reach US$ 4.5 Billion by 2032, exhibiting a CAGR of 13.5% during 2024-2032. 


Market Summary:

  • On the basis of the product, the market has been divided into consumables, kits and reagents, enzymes, and instrument and software. Among these, consumables represented the largest segment.
  • Based on the technology, the market has been classified into polymerase chain reaction (PCR), microarray, sequencing, and others. At present, sequencing accounts for the largest market share.
  • On the basis of application, the market has been divided into gene therapy, clinical research, diagnostics, and others. Currently, clinical research represents the largest segment.
  • Based on the end user, the market has been divided into hospital and diagnostic laboratories, pharmaceutical and biotechnology companies, and research and academia. Among these, pharmaceutical and biotechnology companies accounted for the largest market share.
  • On a regional basis, the market has been categorized into North America (the United States and Canada), Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and Others), Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and Others), Latin America (Brazil, Mexico, and Others), and Middle East and Africa. Among these, North America represented the largest market.
  • The competitive landscape of the industry has also been examined, with some of the key players being Abcam plc., Active Motif Inc., Diagenode S.A. (Hologic Inc.), EpiGentek Group Inc., Illumina Inc., Merck KGaA, New England Biolabs Inc., PerkinElmer Inc., Qiagen N.V., Thermo-Fisher Scientific Inc., Zymo Research Corporation, etc.

Report Coverage:

Report Features Details
Base Year of the Analysis 2023
Historical Period 2018-2023
Forecast Period 2024-2032
Units US$ Billion
Products Covered Consumables, Kits and Reagents, Enzymes, Instrument and Software
Technologies Covered Polymerase Chain Reaction (PCR), Microarray, Sequencing, Others
Applications Covered Gene Therapy, Clinical Research, Diagnostics, Others
End Users Covered Hospital and Diagnostic Laboratories, Pharmaceutical and Biotechnology Companies, Research and Academia
Regions Covered  Asia Pacific, Europe, North America, Latin America, Middle East and Africa
Countries Covered United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico
Companies Covered Abcam plc., Active Motif Inc., Diagenode S.A. (Hologic Inc.), EpiGentek Group Inc., Illumina Inc., Merck KGaA, New England Biolabs Inc., PerkinElmer Inc., Qiagen N.V., Thermo-Fisher Scientific Inc., Zymo Research Corporation, etc.
Customization Scope 10% Free Customization
Report Price and Purchase Option Single User License: US$ 3899
Five User License: US$ 4899
Corporate License: US$ 5899
Post-Sale Analyst Support 10-12 Weeks
Delivery Format PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)


About Us:

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.


Contact Us:

IMARC Group
134 N 4th St.
Brooklyn, NY 11249, USA
Email: Sales@imarcgroup.com
Americas:- +1 631 791 1145 | Africa and Europe :- +44-753-713-2163 | Asia: +91-120-433-0800

Need more help?

  • Speak to our experienced analysts for insights on the current market scenarios.
  • Include additional segments and countries to customize the report as per your requirement.
  • Gain an unparalleled competitive advantage in your domain by understanding how to utilize the report and positively impacting your operations and revenue.
  • For further assistance, please connect with our analysts.
Global DNA Methylation Market to Reach US$ 4.5 Billion by 2032, Propelled by Increasing Prevalence of Chronic Diseases
Purchase options




Benefits of Customization

Personalize this research

Triangulate with your data

Get data as per your format and definition

Gain a deeper dive into a specific application, geography, customer, or competitor

Any level of personalization

Get in Touch With Us
UNITED STATES

Phone: +1-631-791-1145

INDIA

Phone: +91-120-433-0800

UNITED KINGDOM

Phone: +44-753-713-2163

Email: sales@imarcgroup.com

Client Testimonials

Aktive Services

IMARC made the whole process easy. Everyone I spoke with via email was polite, easy to deal with, kept their promises regarding delivery timelines and were solutions focused. From my first contact, I was grateful for the professionalism shown by the whole IMARC team. I recommend IMARC to all that need timely, affordable information and advice. My experience with IMARC was excellent and I can not fault it.

Read More
Greenfish S.A.

The IMARC team was very reactive and flexible with regard to our requests. A very good overall experience. We are happy with the work that IMARC has provided, very complete and detailed. It has contributed to our business needs and provided the market visibility that we required

Read More
Colruyt Group

We were very happy with the collaboration between IMARC and Colruyt. Not only were your prices competitive, IMARC was also pretty fast in understanding the scope and our needs for this project. Even though it was not an easy task, performing a market research during the COVID-19 pandemic, you were able to get us the necessary information we needed. The IMARC team was very easy to work with and they showed us that it would go the extra mile if we needed anything extra

Read More
KRISHAK BHARTI CO-OP LTD

Last project executed by your team was as per our expectations. We also would like to associate for more assignments this year. Kudos to your team.

Read More
Zee Media Corp. Ltd.

We would be happy to reach out to IMARC again, if we need Market Research/Consulting/Consumer Research or any associated service. Overall experience was good, and the data points were quite helpful.

Read More
Arabian Plastic Manufacturing Company Ltd.

The figures of market study were very close to our assumed figures. The presentation of the study was neat and easy to analyse. The requested details of the study were fulfilled. My overall experience with the IMARC Team was satisfactory.

Read More
Sumitomo Corporation

The overall cost of the services were within our expectations. I was happy to have good communications in a timely manner. It was a great and quick way to have the information I needed.

Read More
Hameln Rds

My questions and concerns were answered in a satisfied way. The costs of the services were within our expectations. My overall experience with the IMARC Team was very good.

Read More
Quality Consultants BV

I agree the report was timely delivered, meeting the key objectives of the engagement. We had some discussion on the contents, adjustments were made fast and accurate. The response time was minimum in each case. Very good. You have a satisfied customer.

Read More
TATA Advanced Systems Limited

We would be happy to reach out to IMARC for more market reports in the future. The response from the account sales manager was very good. I appreciate the timely follow ups and post purchase support from the team. My overall experience with IMARC was good.

Read More
Stax

IMARC was a good solution for the data points that we really needed and couldn't find elsewhere. The team was easy to work, quick to respond, and flexible to our customization requests.

Read More